InVitro International: The Irvine developer of toxicity...

InVitro International: The Irvine developer of toxicity tests reported a loss of $727,191, or 12 cents a share, for its latest fiscal quarter. That compared to a loss of $861,295, or 17 cents a share, for the same period a year earlier. Revenue for the company’s first fiscal quarter, which ended Dec. 31, increased 30%, to $343,809 from $264,136.